Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

AZ strengthens Daiichi Sankyo partnership with new ADC deal

AZ strengthens Daiichi Sankyo partnership with new ADC deal

Both companies will jointly develop and commercialise DS-1062 worldwide, apart from in Japan where Daiichi will retain exclusive rights.

Tecentriq misses the mark in advanced ovarian cancer

Tecentriq misses the mark in advanced ovarian cancer AZ is awaiting additional decisions on Imfinzi in first-line ES-SCLC in Europe and Japan before the end of the year, and the drug is already approved for this indication

Novartis reveals full phase 3 results for Enerzair Breezhaler

Novartis reveals full phase 3 results for Enerzair Breezhaler So far, medium- and high-doses of Novartis’ drug have been approved in Japan, and high-dose Enerzair Breezhaler has also been approved in the EU and Canada, with these regulatory

Multichannel engagement and the need for greater understanding of European markets

Multichannel engagement and the need for greater understanding of European markets and Japan in the uptake of digital marketing – the volume share of digital promotional activity is just 11% compared with 21% in the US and 47% in Japan.

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug The companies have split the cost of bringing the drug to market and will share in global profits, with the exception of Japan where Daiichi retains exclusive rights.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home...
The importance of health literacy in patient recruitment materials
Have you ever read something that instantly made you want to read on? Or have you begun to read something, and eventually given up because it didn’t resonate with you?...
Secondary effects of COVID-19 on the healthcare system and patients
We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions....

Infographics